These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19299008)

  • 41. Helicobacter pylori and non-malignant diseases.
    Furuta T; Delchier JC
    Helicobacter; 2009 Sep; 14 Suppl 1():29-35. PubMed ID: 19712165
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of chitosan/heparin nanoparticle-encapsulated cytolethal distending toxin for gastric cancer therapy.
    Lai CK; Lu YL; Hsieh JT; Tsai SC; Feng CL; Tsai YS; Tsai PC; Su HL; Lin YH; Lai CH
    Nanomedicine (Lond); 2014 May; 9(6):803-17. PubMed ID: 24024568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Crucial roles of Helicobacter pylori infection in the pathogenesis of gastric cancer and gastric mucosa-associated lymphoid tissue (MALT) lymphoma].
    Ota H; Asano N; Yamauchi K; Akamatsu T
    Rinsho Byori; 2009 Sep; 57(9):861-9. PubMed ID: 19860212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acid-responsive gene regulation in the human pathogen Helicobacter pylori.
    Pflock M; Kennard S; Finsterer N; Beier D
    J Biotechnol; 2006 Oct; 126(1):52-60. PubMed ID: 16713649
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gastric antibacterial efficiency is different for pepsin A and C.
    Schreiber S; Bücker R; Groll C; Azevedo-Vethacke M; Scheid P; Gatermann S; Josenhans C; Suerbaum S
    Arch Microbiol; 2006 Jan; 184(5):335-40. PubMed ID: 16333616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combating Helicobacter pylori infections with mucoadhesive nanoparticles loaded with Garcinia mangostana extract.
    Pan-in P; Tachapruetinun A; Chaichanawongsaroj N; Banlunara W; Suksamrarn S; Wanichwecharungruang S
    Nanomedicine (Lond); 2014 Mar; 9(3):457-68. PubMed ID: 23731457
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The pathological effect of Helicobacter pylori infection on liver tissues in mice.
    Huang Y; Tian XF; Fan XG; Fu CY; Zhu C
    Clin Microbiol Infect; 2009 Sep; 15(9):843-9. PubMed ID: 19392901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of glycan expression and adhesion of mouse-adapted strains and clinical isolates of Helicobacter pylori.
    Chionh YT; Walduck AK; Mitchell HM; Sutton P
    FEMS Immunol Med Microbiol; 2009 Oct; 57(1):25-31. PubMed ID: 19624738
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inflammation, immunity, and vaccines for Helicobacter pylori.
    D'Elios MM; Andersen LP
    Helicobacter; 2009 Sep; 14 Suppl 1():21-8. PubMed ID: 19712164
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Helicobacter pylori infection and family history of gastric cancer decrease expression of FHIT tumor suppressor gene in gastric mucosa of dyspeptic patients.
    Stec-Michalska K; Peczek L; Michalski B; Wisniewska-Jarosinska M; Krakowiak A; Nawrot B
    Helicobacter; 2009 Oct; 14(5):126-34. PubMed ID: 19751438
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral bioavailability of insulin contained in polysaccharide nanoparticles.
    Sarmento B; Ribeiro A; Veiga F; Ferreira D; Neufeld R
    Biomacromolecules; 2007 Oct; 8(10):3054-60. PubMed ID: 17877397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Helicobacter pylori causes runx3 gene methylation and its loss of expression in gastric epithelial cells, which is mediated by nitric oxide produced by macrophages.
    Katayama Y; Takahashi M; Kuwayama H
    Biochem Biophys Res Commun; 2009 Oct; 388(3):496-500. PubMed ID: 19665002
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved in vitro model systems for gastrointestinal infection by choice of cell line, pH, microaerobic conditions, and optimization of culture conditions.
    Lindén SK; Driessen KM; McGuckin MA
    Helicobacter; 2007 Aug; 12(4):341-53. PubMed ID: 17669108
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of novel pH-sensitive thiolated chitosan/PMLA nanoparticles for amoxicillin delivery to treat Helicobacter pylori.
    Arif M; Dong QJ; Raja MA; Zeenat S; Chi Z; Liu CG
    Mater Sci Eng C Mater Biol Appl; 2018 Feb; 83():17-24. PubMed ID: 29208276
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of Helicobacter pylori eradication on incidence of gastric cancer in human and animal models: underlying biochemical and molecular events.
    Kabir S
    Helicobacter; 2009 Jun; 14(3):159-71. PubMed ID: 19702845
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Helicobacter pylori in biopsy specimen of gastric mucosa: frequency and correlation of rapid urease test with histology].
    Perko Z; Blazanović A; Katicić M; Mimica Z; Cala Z; Druzijanić N
    Lijec Vjesn; 2002; 124(6-7):190-4. PubMed ID: 19658335
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FOXP3-expressing CD4(+) T-cell numbers increase in areas of duodenal gastric metaplasia and are associated to CD4(+) T-cell aggregates in the duodenum of Helicobacter pylori-infected duodenal ulcer patients.
    Kindlund B; Sjöling A; Hansson M; Edebo A; Hansson LE; Sjövall H; Svennerholm AM; Lundin BS
    Helicobacter; 2009 Jun; 14(3):192-201. PubMed ID: 19702849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TNF-alpha expression in gastric mucosa of individuals infected with different virulent Helicobacter pylori strains.
    Zalewska-Ziob M; Adamek B; Strzelczyk JK; Gawron K; Jarzab B; Gubała E; Kula D; Krakowczyk Ł; Sieroń A; Wiczkowski A
    Med Sci Monit; 2009 Jun; 15(6):BR166-71. PubMed ID: 19478694
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Davilla elliptica and Davilla nitida: gastroprotective, anti-inflammatory immunomodulatory and anti-Helicobacter pylori action.
    Kushima H; Nishijima CM; Rodrigues CM; Rinaldo D; Sassá MF; Bauab TM; Stasi LC; Carlos IZ; Brito AR; Vilegas W; Hiruma-Lima CA
    J Ethnopharmacol; 2009 Jun; 123(3):430-8. PubMed ID: 19501275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polysaccharide-based polyelectrolyte complex nanoparticles from chitosan, heparin, and hyaluronan.
    Boddohi S; Moore N; Johnson PA; Kipper MJ
    Biomacromolecules; 2009 Jun; 10(6):1402-9. PubMed ID: 19371056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.